Company / Revenue per Share
Gilead Sciences Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$23.63
FY2025
5-year range
$17.90 / $23.63
FY2021-FY2025
Trend
+2.4%
vs FY2024
Sector context
#23 of 154
Health Care
What the data says
Gilead Sciences's revenue per share of $23.63 is higher than 85% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 4 consecutive years, from $17.90 in FY2021 to $23.63 in FY2025.
Based on SEC 10-K filings.
23.63 in FY2025 with a 5-year CAGR of +3.9%. Top quartile in the Health Care sector.
Improved from $21.90 to $23.63 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Sector benchmark
+56.6% above sector average
Key checks
Key Insights
- Gilead Sciences's revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 2.4% year-over-year.
- Ranks #23 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2017.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.63 | +2.4% |
| FY2024 | $23.08 | +5.4% |
| FY2023 | $21.90 | +11.2% |
| FY2022 | $19.69 | +10.0% |
| FY2021 | $17.90 | -8.2% |
| FY2020 | $19.50 | -4.2% |
| FY2019 | $20.36 | -12.4% |
| FY2018 | $23.23 | -6.7% |
| FY2017 | $24.92 | +42.3% |
| FY2016 | $17.50 | -19.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026